Management of recurrent or metastatic endometrial cancer in Germany: results of the nationwide AGO pattern of care studies from the years 2013, 2009 and 2006
详细信息 查看全文
- 作者：Marco Johannes Battista ; Marcus Schmidt…
- 关键词：Endometrial cancer ; Pattern of care ; Radiotherapy ; Chemotherapy ; Endocrine treatment
- 刊名：Archives of Gynecology and Obstetrics
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：292
- 期：6
- 页码：1355-1360
- 全文大小：358 KB
- 参考文献：1.Geb盲rmutterk枚rper (2010) Krebs in Deutschland 80鈥?3. Accessed at http://鈥媤ww.鈥媟ki.鈥媎e/鈥婯rebs/鈥婦E/鈥婥ontent/鈥婸ublikationen/鈥婯rebs_鈥媔n_鈥婦eutschland/鈥媖id_鈥?013/鈥媖id_鈥?013_鈥媍54-55_鈥媑ebaermutterkoer鈥媝er.鈥媝df;jsessionid=鈥婦687D7570E564374鈥婥AB3C53CCABF8F0E鈥?鈥?_鈥媍id390?鈥媉鈥媉鈥媌lob=鈥媝ublicationFile
2.Creutzberg CL, van Putten WLJ, Koper P et al (2003) Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 89:201鈥?09CrossRef PubMed
3.Fleisch MC, Pantke P, Beckmann MW et al (2007) Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. J Surg Oncol 95:476鈥?84CrossRef PubMed
4.Westin SN, Rallapalli V, Fellman B et al (2014) Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol 134:546鈥?51PubMed Central CrossRef PubMed
5.Temkin SM, Fleming G (2009) Current treatment of metastatic endometrial cancer. Cancer Control 16:38鈥?5PubMed
6.Humber CE, Tierney J, Symonds R (2007) Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol 18:409鈥?20CrossRef PubMed
7.Sommeijer DW, Sjoquist KM, Friedlander M (2013) Hormonal treatment in recurrent and metastatic gynaecological cancers: a review of the current literature. Curr Oncol Reports 15:541鈥?48CrossRef
8.Bradford LS, Rauh-Hain JA, Schorge J et al (2013) Advances in the management of recurrent endometrial cancer. Am J Clin Oncol, PMID 23764681
9.Battista MJ, Schmidt M, Rieks N et al (2014) Nationwide analysis on surgical procedures for patients with endometrial cancer in Germany: Results of the AGO pattern of care studies from the years 2013, 2009, and 2006. J Canc Res Clin Oncol 140:2087鈥?093CrossRef
10.Battista MJ, Schmidt M, Rieks N et al (2015) Adjuvant treatment decisions for patients with endometrial cancer in Germany: results of the nationwide AGO pattern of care studies from the years 2013, 2009, and 2006. J Canc Res Clin Oncol 141:555鈥?62CrossRef
11.Battista MJ, Steiner E, Rieks N et al (2013) Nationwide analysis on surgical staging procedures and systemic treatment for patients with endometrial cancer in Germany. Int J Gynecol Canc 23:105鈥?12CrossRef
12.Fiorica JV, Brunetto V, Hanjani P et al (2004) Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:10鈥?4CrossRef PubMed
13.Whitney C, Brunetto V, Zaino R et al (2004) Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:4鈥?CrossRef PubMed
14.Rose PG, Brunetto V, VanLe L et al (2000) A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 78:212鈥?16CrossRef PubMed
15.Thigpen BT, Brady MF, Homesley HD et al (2001) Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol 19:364鈥?67PubMed
16.Ma B, Oza A, Eisenhauer E et al (2004) The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers鈥揳 study of the National Cancer Institute of Canada Clinical Trials Group. Int J Gynecol Canc 14:650鈥?58CrossRef
17.Emons G, G眉nthert A, Thiel F et al (2013) Phase II study of fulvestrant 250聽mg/month in patients with recurrent or metastatic endometrial cancer: a study of the Arbeitsgemeinschaft Gyn盲kologische Onkologie. Gynecol Oncol 129:495鈥?99CrossRef PubMed
18.Lissoni A, Zanetta G, Losa G et al (1996) Phase II study of paclitaxel as salvage treatment in advancer endometrial cancer. Ann Oncol 13:861鈥?63CrossRef
19.Ball HG, Blessing JA, Lentz SS et al (1996) Phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium. Gynecol Oncol 281:278鈥?81CrossRef
20.Lincoln S, Blessing JA, Lee RB et al (2003) Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol 88:277鈥?81CrossRef PubMed
21.Hirai Y, Hasumi K, Onose R et al (2004) Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group. Gynecol Oncol 94:471鈥?76CrossRef PubMed
22.Obel J, Friberg G, Fleming G (2006) Chemotherapy in endometrial cancer. Clin Adv Hematol Oncol 6:459鈥?68
23.Fleming GF, Brunetto V, Cella D et al (2004) Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 22:2159鈥?166CrossRef PubMed
24.Miller D, Filiaci V, Fleming G et al (2012) Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 125:771CrossRef - 作者单位：Marco Johannes Battista (1)
Marcus Schmidt (1)
Michael Eichbaum (2) (5)
Katrin Almstedt (1)
Anne-Sophie Heimes (1)
Peter Mallmann (3) (5)
Gerald Hoffmann (1)
Eric Steiner (4) (5)
1. Department of Gynecology and Obstetrics, University Hospital Mainz, Langenbeckstr. 1, 55131, Mainz, Germany
2. Department of Gynecology and Obstetrics, Marienkrankenhaus Frankfurt, Frankfurt, Germany
5. Scientific Board Uterine Neoplasm of the Arbeitsgemeinschaft Gyn盲kologische Onkologie (AGO), Taufkirchen, Germany
3. Department of Gynecology and Obstetrics, University Hospital of Cologne, Cologne, Germany
4. Department of Gynecology and Obstetrics, GP Ruesselsheim, Ruesselsheim, Germany - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Gynecology
Obstetrics and Perinatology
Endocrinology
Human Genetics - 出版者：Springer Berlin / Heidelberg
- ISSN：1432-0711
文摘
Purpose The available literature on the treatment options for recurrent or metastatic endometrial cancer (EC) is full of controversies. Therefore, we explore the results of the AGO pattern of care studies from the years 2013, 2009 and 2006.